Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors

被引:118
作者
Short, JJ
Pereboev, AV
Kawakami, Y
Vasu, C
Holterman, MJ
Curiel, DT
机构
[1] Univ Alabama, Gene Therapy Ctr, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA
[3] Univ Alabama, Dept Pathol, Div Human Gene Therapy, Birmingham, AL 35294 USA
[4] Univ Alabama, Dept Surg, Div Human Gene Therapy, Birmingham, AL 35294 USA
[5] Univ Illinois, Dept Surg, Chicago, IL 60612 USA
[6] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA
关键词
adenovirus; receptor; CD80; CD86; subgroup B; co-stimulatory molecules;
D O I
10.1016/j.virol.2004.02.016
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Most viruses exploit a variety of host cellular proteins as primary cellular attachment receptors in the context of successful execution of infection. Furthermore, many viral agents have evolved precise mechanisms to subvert host immune recognition to achieve persistence. Herein we present data indicating that adenovirus (Ad) serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors. CD80 and CD86 are co-stimulatory molecules that are present on mature dendritic cells and B lymphocytes and are involved in stimulating T-lymphocyte activation. To our knowledge, this is one of the first demonstrations of a virus utilizing immunologic accessory molecules as a primary means of cellular entry. This finding suggests a mechanism whereby viral exploitation of these proteins as receptors may achieve both goals of cellular entry and evading the immune system. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:349 / 359
页数:11
相关论文
共 49 条
[1]  
ALBIGESRIZO C, 1991, J BIOL CHEM, V266, P3961
[2]  
AMBERG N, 2002, J VIROL, V76, P8834
[3]   B70 ANTIGEN IS A 2ND LIGAND FOR CTLA-4 AND CD28 [J].
AZUMA, M ;
ITO, D ;
YAGITA, H ;
OKUMURA, K ;
PHILLIPS, JH ;
LANIER, LL ;
SOMOZA, C .
NATURE, 1993, 366 (6450) :76-79
[4]   Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5 [J].
Bergelson, JM ;
Cunningham, JA ;
Droguett, G ;
KurtJones, EA ;
Krithivas, A ;
Hong, JS ;
Horwitz, MS ;
Crowell, RL ;
Finberg, RW .
SCIENCE, 1997, 275 (5304) :1320-1323
[5]   Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR [J].
Bewley, MC ;
Springer, K ;
Zhang, YB ;
Freimuth, P ;
Flanagan, JM .
SCIENCE, 1999, 286 (5444) :1579-1583
[6]   Expression and induction of costimulatory and adhesion molecules on acute myeloid leukemic cells: Implications for adoptive immunotherapy [J].
Brouwer, RE ;
Zwinderman, KH ;
Kluin-Nelemans, HC ;
van Luxemburg-Heijs, SAP ;
Willemze, R ;
Falkeknburg, JHF .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (02) :161-168
[7]   B70/B7-2 IS IDENTICAL TO CD86 AND IS THE MAJOR FUNCTIONAL LIGAND FOR CD28 EXPRESSED ON HUMAN DENDRITIC CELLS [J].
CAUX, C ;
VANBERVLIET, B ;
MASSACRIER, C ;
AZUMA, M ;
OKUMURA, K ;
LANIER, LL ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (05) :1841-1847
[8]   The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction [J].
Cohen, CJ ;
Shieh, JTC ;
Pickles, RJ ;
Okegawa, T ;
Hsieh, JT ;
Bergelson, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (26) :15191-15196
[9]   Enhanced neuroblastoma transduction for an improved antitumor vaccine [J].
Davidoff, AM ;
Stevenson, SC ;
McClelland, A ;
Shochat, SJ ;
Vanin, EF .
JOURNAL OF SURGICAL RESEARCH, 1999, 83 (02) :95-99
[10]   HUMAN ADENOVIRUS SEROTYPE-3 (AD3) AND THE AD3 FIBER PROTEIN BIND TO A 130-KDA MEMBRANE-PROTEIN ON HELA-CELLS [J].
DIGUILMI, AM ;
BARGE, A ;
KITTS, P ;
GOUT, E ;
CHROBOCZEK, J .
VIRUS RESEARCH, 1995, 38 (01) :71-81